Incidence of tick-borne encephalitis in unvaccinated populations across Europe (2020-2023)

IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES
Kate Halsby , Alexander Davidson , Julie Davis , Kyra Zens , Gerhard Dobler , Andreas Pilz , Frederick J. Angulo , Pingping Zhang , Patrick H. Kelly , James H. Stark
{"title":"Incidence of tick-borne encephalitis in unvaccinated populations across Europe (2020-2023)","authors":"Kate Halsby ,&nbsp;Alexander Davidson ,&nbsp;Julie Davis ,&nbsp;Kyra Zens ,&nbsp;Gerhard Dobler ,&nbsp;Andreas Pilz ,&nbsp;Frederick J. Angulo ,&nbsp;Pingping Zhang ,&nbsp;Patrick H. Kelly ,&nbsp;James H. Stark","doi":"10.1016/j.ijid.2025.108052","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Tick-borne encephalitis (TBE) is a vaccine-preventable disease. While many European countries conduct TBE surveillance, resulting incidence estimates do not distinguish between vaccinated and unvaccinated populations. To understand TBE risk to unvaccinated individuals, we assessed incidence among unvaccinated populations in Europe.</div></div><div><h3>Methods</h3><div>TBE incidence was calculated as cases per 100,000 population per year (PPY) using publicly available surveillance data for 34 countries (2020-2023). Unvaccinated incidence was calculated for 21 countries using TBE vaccine uptake data from population surveys, and assuming 95.1% of TBE cases were unvaccinated. The number of cases averted by vaccination in 2023 was also estimated.</div></div><div><h3>Results</h3><div>The surveillance-reported TBE incidence (2020-2023) was ≥5 per 100,000 PPY for Lithuania, Latvia, Estonia, Czechia, and Slovenia. When the unvaccinated incidence is calculated, Sweden and Austria also had an incidence ≥5 per 100,000 PPY. In 2023, 2498 TBE cases were estimated to have been averted in 21 countries by vaccination.</div></div><div><h3>Conclusion</h3><div>The incidence of TBE remains a significant public health concern, with &gt;35 million people living in highly endemic areas of Europe. TBE incidence in the unvaccinated population is substantially higher than the incidence of surveillance-reported TBE cases. Enhanced efforts are needed to increase the uptake of preventive measures, including vaccination.</div></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":"160 ","pages":"Article 108052"},"PeriodicalIF":4.3000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971225002747","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Tick-borne encephalitis (TBE) is a vaccine-preventable disease. While many European countries conduct TBE surveillance, resulting incidence estimates do not distinguish between vaccinated and unvaccinated populations. To understand TBE risk to unvaccinated individuals, we assessed incidence among unvaccinated populations in Europe.

Methods

TBE incidence was calculated as cases per 100,000 population per year (PPY) using publicly available surveillance data for 34 countries (2020-2023). Unvaccinated incidence was calculated for 21 countries using TBE vaccine uptake data from population surveys, and assuming 95.1% of TBE cases were unvaccinated. The number of cases averted by vaccination in 2023 was also estimated.

Results

The surveillance-reported TBE incidence (2020-2023) was ≥5 per 100,000 PPY for Lithuania, Latvia, Estonia, Czechia, and Slovenia. When the unvaccinated incidence is calculated, Sweden and Austria also had an incidence ≥5 per 100,000 PPY. In 2023, 2498 TBE cases were estimated to have been averted in 21 countries by vaccination.

Conclusion

The incidence of TBE remains a significant public health concern, with >35 million people living in highly endemic areas of Europe. TBE incidence in the unvaccinated population is substantially higher than the incidence of surveillance-reported TBE cases. Enhanced efforts are needed to increase the uptake of preventive measures, including vaccination.
欧洲未接种疫苗人群中蜱传脑炎的发病率(2020-2023)
背景:蜱传脑炎(TBE)是一种疫苗可预防的疾病。虽然许多欧洲国家开展脑炎监测,但由此产生的发病率估计并未区分接种疫苗和未接种疫苗的人群。为了了解未接种疫苗个体的TBE风险,我们评估了欧洲未接种疫苗人群的发病率。方法:利用34个国家(2020-2023年)的公开监测数据,以每年每10万人口(PPY)的病例数计算TBE发病率。使用来自人口调查的TBE疫苗接种数据计算了21个国家的未接种发生率,并假设95.1%的TBE病例未接种疫苗。还估计了2023年通过接种疫苗避免的病例数。结果:监测报告的立陶宛、拉脱维亚、爱沙尼亚、捷克和斯洛文尼亚的TBE发病率(2020-2023年)≥5 / 100,000 py。当计算未接种疫苗的发病率时,瑞典和奥地利的发病率也≥5 / 100,000 PPY。2023年,估计在21个国家通过接种疫苗避免了2498例脑炎病例。结论:TBE的发病率仍然是一个重要的公共卫生问题,有1.35亿人生活在欧洲高流行地区。未接种疫苗人群的脑炎发病率大大高于监测报告的脑炎病例发病率。需要加强努力,增加采取预防措施,包括接种疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信